Esperion Therapeutics promotes Ben Halladay to CFO | Crain's Detroit Business
Ann Arbor-based drug company Esperion Therapeutics Inc. has a new top financial executive. Esperion (NASDAQ: ESPR) promoted Ben Halladay to CFO, it said in a news release late Wednesday. Halladay, 37, who joined Esperion in 2020 and was most recently a senior director of financial planning and…
Bartram Linkedin Richard Bartram Ben Halladay Sheldon Koenig Esperion Therapeutics Inc Syracuse University
Source: crainsdetroit.com